What is the most common site of cervical cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Most Common Site of Cervical Cancer

The transformation zone (TZ) of the cervix is the most common site where cervical cancer develops, with squamous cell carcinomas accounting for 70-80% of all cervical cancers 1, 2.

Anatomical Location and Cancer Development

The cervix has a complex epithelial organization consisting of three distinct regions:

  • Ectocervix: Lined by stratified squamous epithelium
  • Endocervix: Lined by columnar epithelium
  • Transformation zone (TZ): The critical junction area where squamous metaplasia occurs

Most cervical cancers arise specifically at the transformation zone, which represents the area where the stratified squamous epithelium of the ectocervix meets the columnar epithelium of the endocervix 2, 3. This region is particularly vulnerable because it undergoes active metaplastic changes, where columnar epithelium transforms into squamous epithelium—a process mediated by cervical reserve cells.

Why the Transformation Zone is Most Vulnerable

The transformation zone's susceptibility to malignant transformation relates to several factors:

  • Reserve cells at the TZ serve as the primary target for HPV infection 2
  • These specialized stem cells can be derived from either basal cells of the ectocervix or cuboidal cells at the squamocolumnar junction
  • The active metaplastic process creates an environment where HPV can establish persistent infection
  • HPV infection of these diverse cell types facilitates deregulated viral gene expression and neoplastic development 2

Histologic Distribution by Site

Squamous cell carcinomas (70-80% of cervical cancers) predominantly arise from the transformation zone where squamous metaplasia occurs 1.

Adenocarcinomas (10-15% of cervical cancers) more commonly originate from the endocervical columnar epithelium, though they can also develop at the transformation zone 1.

Clinical Implications

Understanding that the transformation zone is the primary site of cancer development explains why:

  • Screening methods (cytology, HPV testing) focus on sampling this specific area
  • Colposcopic examination targets the transformation zone for visualization
  • Early detection strategies emphasize adequate sampling of the squamocolumnar junction
  • Similar transformation zones in other anatomical sites (oropharynx, anus) are also vulnerable to HPV-associated cancers 2

This anatomical specificity underscores the importance of proper sampling technique during screening to ensure adequate cells from the transformation zone are obtained for accurate detection of precancerous and cancerous lesions.

Related Questions

What is the risk of cervical cancer in a person who has never been sexually active?
What risk factors place a woman at high risk for developing cervical cancer?
What are the current ASCCP (American Society for Colposcopy and Cervical Pathology) guidelines for management of high‑risk human papillomavirus (HPV) infection and cervical cancer screening across different age groups and special populations?
Could cervical cancer be the cause of worsening lower abdominal pain in a patient who is 10 months postpartum?
What is the most effective screening test for cervical cancer in average-risk women?
What are the possible causes of peripheral edema in a patient with systemic lupus erythematosus?
Interpret the renal and hepatic laboratory results for an 83-year-old male undergoing preoperative evaluation for eye surgery performed under twilight sedation to determine if he can be cleared for the procedure.
At what age should average-risk women start HPV and Pap (cotesting) screening, and when should the combined test be repeated if the HPV result is positive?
Can you interpret the pending laboratory results for a 72-year-old woman with intermittent right‑wrist pain, yellow‑tinged urine without visible hematuria, occasional urinary bubbles, a two‑week productive cough, nighttime shortness of breath, and GERD symptoms, given that a basic metabolic panel, complete blood count, urinalysis, urine culture, and renal ultrasound have been ordered?
What are the primary signs of ovulation in a normally cycling adult woman?
What are the differences between HSV‑1 and HSV‑2 regarding typical outbreak locations, triggers, and recommended antiviral treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.